Drug class in one race
TNF-alpha drugs for Crohn's Disease
21 tracked TNF-alpha drugs in the Crohn's Disease race. The class explanation lives on the TNF-alpha page; the full indication pipeline across every mechanism is on the Crohn's Disease page.
19 approved / phase 41 Phase 31 Phase 1
Head-to-head evidence: CT-P13 vs Hemay007 · CT-P13 vs JNJ-78934804 · adalimumab vs CT-P13 · adalimumab-aacf (Idacio) vs CT-P13 · adalimumab-aaty (Yuflyma) vs CT-P13 · adalimumab-adaz (Hyrimoz) vs CT-P13